| Dr Tong Ge, MD | |
|
361 Alexander Spring Rd, Carlisle, PA 17015-6940 | |
| (717) 960-3319 | |
| (717) 960-3301 |
| Full Name | Dr Tong Ge |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 40 Years |
| Location | 361 Alexander Spring Rd, Carlisle, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205820826 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD422076 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Reading Hospital | West reading, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tower Health Medical Group | 7618889213 | 577 |
News Archive
Indian and American researchers collaborated to study the trends of transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in two Indian states – Tamil Nadu and Andhra Pradesh. Their study titled, "Epidemiology and transmission dynamics of COVID-19 in two Indian states," was published in the latest issue of the journal Science last week.
Growing concern about rising costs and potential harms of medical care has stimulated interest in assessing physicians' ability to minimize the provision of unnecessary care. Objective: To assess whether graduates of residency programs characterized by low-intensity practice patterns are more capable of managing patients' care conservatively ...
Arthroscopic treatment of a common hip problem that leads to arthritis is successful in terms of restoring range of motion, according to results from a recent Hospital for Special Surgery study.
In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.
In connection with the New York Times' recent coverage of hormone therapy1, Pfizer Inc. today released important facts and context to respond to the newspaper's account. Pfizer believes the coverage is based on a misleading and selective reading of both the science and history of hormone therapy (HT) medicines.
› Verified 3 days ago
| Entity Name | West Reading Radiology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700848280 PECOS PAC ID: 3274434246 Enrollment ID: O20040114000452 |
News Archive
Indian and American researchers collaborated to study the trends of transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in two Indian states – Tamil Nadu and Andhra Pradesh. Their study titled, "Epidemiology and transmission dynamics of COVID-19 in two Indian states," was published in the latest issue of the journal Science last week.
Growing concern about rising costs and potential harms of medical care has stimulated interest in assessing physicians' ability to minimize the provision of unnecessary care. Objective: To assess whether graduates of residency programs characterized by low-intensity practice patterns are more capable of managing patients' care conservatively ...
Arthroscopic treatment of a common hip problem that leads to arthritis is successful in terms of restoring range of motion, according to results from a recent Hospital for Special Surgery study.
In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.
In connection with the New York Times' recent coverage of hormone therapy1, Pfizer Inc. today released important facts and context to respond to the newspaper's account. Pfizer believes the coverage is based on a misleading and selective reading of both the science and history of hormone therapy (HT) medicines.
› Verified 3 days ago
| Entity Name | Tower Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
Indian and American researchers collaborated to study the trends of transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in two Indian states – Tamil Nadu and Andhra Pradesh. Their study titled, "Epidemiology and transmission dynamics of COVID-19 in two Indian states," was published in the latest issue of the journal Science last week.
Growing concern about rising costs and potential harms of medical care has stimulated interest in assessing physicians' ability to minimize the provision of unnecessary care. Objective: To assess whether graduates of residency programs characterized by low-intensity practice patterns are more capable of managing patients' care conservatively ...
Arthroscopic treatment of a common hip problem that leads to arthritis is successful in terms of restoring range of motion, according to results from a recent Hospital for Special Surgery study.
In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.
In connection with the New York Times' recent coverage of hormone therapy1, Pfizer Inc. today released important facts and context to respond to the newspaper's account. Pfizer believes the coverage is based on a misleading and selective reading of both the science and history of hormone therapy (HT) medicines.
› Verified 3 days ago
| Entity Name | West Grove Clinic Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790856078 PECOS PAC ID: 4789685033 Enrollment ID: O20070129000812 |
News Archive
Indian and American researchers collaborated to study the trends of transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in two Indian states – Tamil Nadu and Andhra Pradesh. Their study titled, "Epidemiology and transmission dynamics of COVID-19 in two Indian states," was published in the latest issue of the journal Science last week.
Growing concern about rising costs and potential harms of medical care has stimulated interest in assessing physicians' ability to minimize the provision of unnecessary care. Objective: To assess whether graduates of residency programs characterized by low-intensity practice patterns are more capable of managing patients' care conservatively ...
Arthroscopic treatment of a common hip problem that leads to arthritis is successful in terms of restoring range of motion, according to results from a recent Hospital for Special Surgery study.
In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.
In connection with the New York Times' recent coverage of hormone therapy1, Pfizer Inc. today released important facts and context to respond to the newspaper's account. Pfizer believes the coverage is based on a misleading and selective reading of both the science and history of hormone therapy (HT) medicines.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tong Ge, MD 4520 Union Deposit Rd, Harrisburg, PA 17111-2910 Ph: (717) 652-6105 | Dr Tong Ge, MD 361 Alexander Spring Rd, Carlisle, PA 17015-6940 Ph: (717) 960-3319 |
News Archive
Indian and American researchers collaborated to study the trends of transmission of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in two Indian states – Tamil Nadu and Andhra Pradesh. Their study titled, "Epidemiology and transmission dynamics of COVID-19 in two Indian states," was published in the latest issue of the journal Science last week.
Growing concern about rising costs and potential harms of medical care has stimulated interest in assessing physicians' ability to minimize the provision of unnecessary care. Objective: To assess whether graduates of residency programs characterized by low-intensity practice patterns are more capable of managing patients' care conservatively ...
Arthroscopic treatment of a common hip problem that leads to arthritis is successful in terms of restoring range of motion, according to results from a recent Hospital for Special Surgery study.
In the last decade, advances in the understanding of genes promoting hepatic stellate cell (HSC) activation are impressive. However, there are few breakthroughs in therapeutic intervention of hepatic fibrogenesis. Efficient and well-tolerated antifibrotic drugs are lacking and current treatment of hepatic fibrosis is limited to withdrawal of the noxious agent. Research identifying innocuous antifibrotic agents is of high priority and urgently needed.
In connection with the New York Times' recent coverage of hormone therapy1, Pfizer Inc. today released important facts and context to respond to the newspaper's account. Pfizer believes the coverage is based on a misleading and selective reading of both the science and history of hormone therapy (HT) medicines.
› Verified 3 days ago
Dr. Julia E Blum, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 25 Sprint Dr, Carlisle, PA 17015 Phone: 717-960-3750 Fax: 717-960-3734 | |
Dr. Robert Franklin Hall Ii, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 161 Candlelite Dr, Carlisle, PA 17013 Phone: 717-243-3621 Fax: 717-243-1607 | |
Dr. Jennifer Rosenberg, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 25 Sprint Dr, Carlisle, PA 17015 Phone: 717-960-3750 Fax: 717-960-3734 | |
Wallace A Longton, MD Radiology Medicare: Medicare Enrolled Practice Location: 25 Sprint Dr, Carlisle, PA 17015 Phone: 717-960-3726 Fax: 717-960-3734 | |
Dr. David R. Royal, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 850 Walnut Bottom Rd, Carlisle, PA 17013 Phone: 814-643-6207 Fax: 814-643-6165 | |
Dr. Ronald H Malcom, MD Radiology Medicare: Medicare Enrolled Practice Location: 25 Sprint Dr, Carlisle, PA 17015 Phone: 717-960-3750 Fax: 717-960-3734 |